Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies
2017
Background: Depression is a common comorbidity in psoriasis, and both conditions are associated with systemic inflammation. The efficacy of ixekizumab, a high-aff
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
20
References
41
Citations
NaN
KQI